Home Your basket
• Going from the tube feedi...
   Price 8.50 €
• A schwannoma of the hypog...
   Price 8.50 €
• Vocal forcing and posture...
   Price 10.50 €
• What is the effect of diz...
   Price 10.50 €
• Vibrant Soundbridge middl...
   Price 10.50 €
• Guidelines for the clinic...
   Price 12.50 €
• Herniation of the temporo...
   Price 12.50 €
• Aesthetic augmentation of...
   Price 10.50 €
• Treatments of hereditary ...
   Price 10.50 €
• Mucormycosis – early diag...
   Price 10.50 €
• Tuberculous otomastoiditi...
   Price 5.50 €
• Submental flap for auricu...
   Price 8.50 €
• Adenocarcinoma of the eth...
   Price 8.50 €
• Overlay versus underlay t...
   Price 10.50 €
• Congenital cyst and fistu...
   Price 10.50 €
• Mast cells in chronic inf...
   Price 10.50 €
• Paediatric endoscopic sin...
   Price 10.50 €
• Treatment of acute mastoi...
   Price 8.50 €
• What we don’t know about ...
   Price 12.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• Forcing the voice : the c...
   Price 5.50 €
• One-stage surgery of midd...
   Price 8.50 €
• Vertical extended hemi cr...
   Price 5.50 €
• Contribution of the study...
   Price 10.50 €
• Supra and infra hyoid mid...
   Price 10.50 €
• Early evaluation of voice...
   Price 12.00 €
• Blepharoplasty and upper ...
   Price 10.50 €
• Comparative study using A...
   Price 10.50 €
• Kikuchi's disease as the ...
   Price 10.50 €
• International Conference ...
   Price 5.50 €
• Cosmetic radiofrequency...
   Price 10.50 €
• A comparative study of br...
   Price 10.50 €
• Evaluation of the efficie...
   Price 10.50 €
• Hearing aid : practical a...
   Price 10.50 €
• Surgery of mucocele of th...
   Price 10.50 €
• Vibrant Soundbridge for h...
   Price 10.50 €
• Navigation in head and ne...
   Price 10.50 €
• Recurrences of pleomorphi...
   Price 10.50 €
• Brain stem cavernous angi...
   Price 8.50 €
• Rhinoplasty: Morphodynami...
   Price 10.50 €
• Epidermoid carcinoma of p...
   Price 10.50 €
• Results of fine needle as...
   Price 10.50 €
• Sinonasal hemangiopericyt...
   Price 8.50 €
• Time-intensity trade of b...
   Price 10.50 €
• Study of the platysma col...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• Bilateral facial nerve pa...
   Price 5.50 €
• Chronitis tonsillitis...
   Price 8.50 €
• Follow up of tracheostoma...
   Price 12.00 €
• External otitis...
   Price 8.50 €
• Congenital cholesteatoma ...
   Price 5.50 €
• Transgender voice and com...
   Price 12.00 €
• Ectopic thyroid basi-ling...
   Price 10.50 €
• Epidemiology of paediatri...
   Price 10.50 €
• Focus on the BPPV: Semont...
   Price 12.50 €
• A survey of current wound...
   Price 5.50 €
• Sphenochoanal polyp: Repo...
   Price 5.50 €
• Prosody and reading: Temp...
   Price 12.00 €
• Diagnosis of non organic ...
   Price 8.50 €
• Study of the supra-glotti...
   Price 10.50 €
• Far-advanced otosclerosis...
   Price 10.50 €
• Vocal fold structure and ...
   Price 10.50 €
• Social consequence of a d...
   Price 10.50 €
• Invasive cholesteatoma in...
   Price 10.50 €
• Combined transoral and su...
   Price 10.50 €
• Quality of life after oro...
   Price 10.50 €
• Aneurysmal bone cyst of t...
   Price 5.50 €
• Surgery of the semicircul...
   Price 12.50 €
• A retrospective study of ...
   Price 10.50 €
• A case of nasal foreign b...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Pneumoparotid: a case rep...
   Price 8.50 €
• Focus on the BPPV: Semont...
   Price 12.50 €

Total Order 706.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2000 o

RHINOLOGY

Acceptability of topical administration of a combination of corticoid (beclomethasone) and antihistamine (azelastine) in the treatment of allergic rhinitis.


Authors : D. Portmann, M. Le Gal, V. Jessent, J.-L. Verrière (Bordeaux, Lyon)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,4:273-280.

Article published in french
Downloadable PDF document french



Summary : A prospective multicentre study involving 219 patients with seasonal or aperiodic rhinitis was performed to assess the acceptability of a local treatment combining antihistamine (azelastine) and corticoid (beclomethasone) drugs. The drugs were administered either together (morning and evening, with a 5-minute interval) or separately (azelastine in the morning and evening, and beclomethasone later during the morning and in the afternoon) for 15 days. Treatment acceptability was measured by a nine-fold questionnaire (7-point scale, mean score per question). Patient participation, protocol and therapy compliance, and treatment efficacy and tolerance were also studied. The acceptability of the association was satisfactory (mean score for general facility of treatment: 4.7 / 6) and did not differ between administration schedules. Patients found treatment easy, and were not bothered by the bulk of the bottles or the risk of mixing them up. This acceptability was confirmed by the low percentage (4 %) of patients refusing to be included in the study (refusing any treatment by nasal spray). The general acceptability was confirmed by the results for therapy compliance, general efficacy and tolerance: 94.9 % of the patients took more than 75 % of the administrations prescribed, 77.6 % of the patients and 85.2 % of the practitioners judged treatment efficacy as good or excellent, and 84.6 % of the patients and 91.4 % of the practitioners judged tolerance as good or excellent. Moreover, most of the adverse events consisted of minor signs of local intolerance, and were identical to those observed when the two treatments were administered alone.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE